Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 8,484 shares at $70.08 ($592K) on 2018-11-07, disclosed to the SEC on 2018-11-08.
Open-market sale of $592k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.48 | 2,371 | $165K | 27.8% |
| 2 | $69.48 | 2,371 | $165K | 27.8% |
| 3 | $70.08 | 1,871 | $131K | 22.2% |
| 4 | $70.08 | 1,871 | $131K | 22.2% |
| Total | $69.74 avg | 8,484 | $592K | 100% |
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |